The D.C. Circuit considers a dispute over paintings by the Dutch artist Piet Mondrian. Trustees claiming through his heir say the works were lent to a museum in Krefeld, Germany, for an exhibition in 1929, but never returned. They seek the remaining paintings and compensation for others sold or exchanged after the war. The city disputes their ownership claim. Mondrian fled Nazi persecution and died in New York in 1944. The trustees say persecution prevented him from recovering the works, and that the museum later wrongfully kept or disposed of them. A federal district court dismissed their suit under the Foreign Sovereign Immunities Act. That law generally protects foreign states and their agencies from suit, subject to exceptions. Here the claimed exception concerns property taken in violation of international law. The trustees will argue that persecution and the museum's later conduct qualify. The museum will respond that these allegations do not establish a governmental taking, even
The Second Circuit considers whether Derrick White's trial lawyer should have challenged police access to his cellphone location records. White was convicted of assault and weapon offenses after a man was shot in the foot in New York. Two eyewitnesses identified him, and cell-tower records placed his phone near the shooting. Police obtained those records with a court order, not a search warrant. His trial lawyer did not ask to exclude them. The trial preceded Carpenter, the Supreme Court decision recognizing Fourth Amendment protection for historical cellphone location data. The state courts rejected White's ineffective-assistance claim, and a federal district court denied his habeas petition. Federal habeas review challenges a state conviction on federal constitutional grounds, with deference to state-court rulings. White will argue that counsel should have preserved a plausible challenge for appeal, and that the phone evidence mattered to the result. The state will respond that couns
The D.C. Circuit reviews the revocation of Dr. Mark Huff's federal authority to prescribe controlled drugs. The dispute began when Huff sought to move his registration from Utah to Georgia, prompting a DEA investigation. The agency found that he had not been candid about a fentanyl relapse and subsequent treatment. Huff maintained that he had misunderstood questions about treatment. He requested an administrative hearing and submitted a brief description of his proposed testimony. The administrative law judge found that description inadequate and terminated the hearing proceedings. DEA's administrator then revoked Huff's registration. Huff will argue that his summary complied with the judge's order and that denying him a hearing was improper. DEA will defend the judge's authority to enforce procedural requirements. Listen for the difference between limiting testimony that was not disclosed in advance and denying a hearing altogether. Mark Huff, M.D. v. Drug Enforcement Administration (
The Seventh Circuit considers whether SuperValu can face civil penalties for false pharmacy bills even without proven government losses. The dispute began with a price-matching program: cash customers could obtain discounted prescriptions, while the pharmacies reported higher prices as their usual and customary charges to government health programs. Whistleblowers sued under the False Claims Act, a law that lets private plaintiffs pursue fraud claims in the government's name. A pharmacy benefit manager, or PBM, is a private intermediary that helps administer prescription benefits. This case already reached the Supreme Court in 2023, which addressed the defendants' knowledge, not whether every bill was false. After the case returned for trial, the jury found for the whistleblowers on knowledge but found they had not proved the false claims caused government losses. The district court entered judgment for SuperValu and denied a new trial. The whistleblowers will argue that civil penaltie
The Supreme Court considers a labor dispute involving Sun Valley Orchards, a New Jersey fruit-and-vegetable farm that hired seasonal workers through the H-two-A visa program in 2015. That program allows foreign agricultural workers to come to the United States, with protections for them and domestic workers doing corresponding jobs. Sun Valley employed ninety-six foreign workers and fifty-one domestic workers. Labor Department investigators said the farm failed to keep promises about housing, transportation, kitchen access, and guaranteed work. For example, workers had been promised free cooking facilities, but the agency found they lacked meaningful kitchen access and were charged for a meal plan instead. A Labor Department administrative law judge ordered more than half a million dollars in civil penalties and back wages, and the department's review board upheld that order. The farm challenged the agency process in federal court. After a district court rejected its claims, the Third
The Second Circuit considers investor Arata's securities-fraud lawsuit against Standard Lithium. The company was testing a process to extract lithium from salty water at an Arkansas demonstration plant. Arata says its statements about high recovery rates and large production volumes overstated what the plant could actually do. Reports challenging the company's claims were followed by sharp drops in its stock price. The company disputes the reports' calculations and says it warned investors that the project was still being tested. A federal judge dismissed the case, finding the alleged misleading statements and fraudulent intent insufficiently pleaded. Arata will argue that warnings about future risks did not excuse withholding disappointing results already known to management. Standard Lithium will argue that its statements described laboratory results and potential capacity, not proven commercial production. Arata v. Standard Lithium Ltd. (No. 25-2821) — U.S. Court of Appeals for the
The Second Circuit hears the criminal appeals of Zhu and Zheng. The case grew out of a campaign to pressure a Chinese couple living in New Jersey to return to China. Zhu hired a private investigator to locate them, while Zheng posted a threatening note at their home. The note used a prison sentence and the family's safety to pressure the husband to return. A jury convicted both men of stalking-related crimes. It also convicted Zhu of acting for China without notifying the U.S. attorney general, but acquitted Zheng of the foreign-agent charges. The trial judge refused to overturn their convictions. Zhu will challenge limits on his defense evidence and argue that his police interview should have been excluded. Zheng will dispute whether his brief involvement made him part of the larger stalking agreement, and will challenge limits on cross-examination. The government will defend the trial rulings and argue that the evidence supports the convictions. United States v. Yong Zhu and Congying
The D.C. Circuit hears Gottlieb Memorial Hospital and other teaching hospitals challenge a change in their Medicare payments. Medicare pays teaching hospitals an extra amount to help cover costs associated with training doctors. That amount depends in part on the ratio of doctors in training to hospital beds: counting more beds reduces the payment. The agency began including labor and delivery beds that had previously been excluded, and these hospitals received less money. They challenged the rule, but a federal district judge upheld it, finding both statutory authority and a reasonable explanation for the change. The hospitals will argue that Congress preserved the earlier calculation and that the agency failed to justify changing this measure of teaching intensity. The government will argue that Congress authorized it to define available beds, and that counting labor and delivery beds consistently with another Medicare payment program was reasonable. Gottlieb Memorial Hospital, et al
The Seventh Circuit reviews the dismissal of a Hammond police sergeant’s discrimination lawsuit. Martinez says the department ridiculed her after she sought treatment for post-traumatic stress disorder. She says a fitness-for-duty evaluation led to administrative leave and removal from her traffic assignment. She also alleges sexual harassment and retaliation after she complained. A federal judge found her complaint insufficient and refused a further amendment. Martinez will argue that the judge demanded too much detail before discovery and should have allowed her to revise the complaint. The city will argue that her account of past grievances does not plausibly connect the facts to the legal claims. Carmen Martinez v. City of Hammond, Indiana (No. 25-3066) — U.S. Court of Appeals for the Seventh Circuit, argued November 9, 2026. Sources: Official Seventh Circuit oral argument — November 9, 2026: District-court opinion and order — Martinez, October 17, 2025:
The Federal Circuit hears a dispute over a photograph attached to a trade-dress settlement. Kaotica accused Iconic Mars of violating its rights in a product’s appearance. The resulting judgment barred Iconic from selling the accused product, identified by an attached photo. Years later, Iconic asked to replace that photo, saying it showed a redesigned product rather than the version covered by the deal. Kaotica disputes that the photo is wrong. The district court refused to change the judgment. Iconic will argue that the rule for correcting clerical mistakes also covers a party’s drafting error. Kaotica will defend the signed agreement and argue that this is not a clerical correction. Kaotica IP Corp. v. Iconic Mars Corporation (No. 25-1883) — U.S. Court of Appeals for the Federal Circuit, argued November 9, 2026. Sources: Official Federal Circuit oral argument — November 9, 2026. Source note: the official file cuts off the judge’s final administrative word after ‘The case is submitted
The Seventh Circuit hears an insurance dispute over lost video evidence. MB Real Estate faced a claim that it had failed to preserve a video. Its insurer, Norguard, provided defense counsel, but waited about five months before warning that this claim was not covered. The insurer nevertheless continued the defense in that lawsuit. After that lawsuit was dismissed, the claimant refiled the video-loss claim, and MB Real Estate settled it. After a bench trial, a federal judge ruled that Norguard could deny coverage. MB Real Estate will argue that surrendering control of its defense was enough to show prejudice. Norguard will argue that the company remained involved in its defense and was not harmed by the delay. Norguard Insurance Company v. MB Real Estate Services, Inc. (No. 25-3238) — U.S. Court of Appeals for the Seventh Circuit, argued November 9, 2026. Sources: Official Seventh Circuit oral argument — November 9, 2026: District-court post-trial memorandum and order — Norguard, Doc. 17
The Second Circuit reviews a ruling against hotel companies in a guest’s negligence lawsuit. Betts called the front desk for an in-room massage, and the hotel arranged an outside therapist. She says he sexually assaulted her during the appointment. He held a professional license, but his New York registration had expired. A federal judge found the hotel companies liable without a trial on that issue. The judge treated the hotel’s violation of New York’s massage-services law as negligence in itself, and found a legal causal link to her injuries. The companies will contest how the statute applies, whether it establishes negligence, and whether the violation caused the assault. Betts will defend the ruling as enforcing protections for massage clients. Betts v. Sixty Lower East Side, LLC (No. 25-2108) — U.S. Court of Appeals for the Second Circuit, argued November 9, 2026. Sources: Official Second Circuit oral argument — November 9, 2026: District-court memorandum and order — Betts, Doc. 7
The Federal Circuit hears Acadia Pharmaceuticals’ patent dispute with generic drugmakers Aurobindo and MSN. The dispute concerns a small-capsule formulation of pimavanserin, a medicine used for hallucinations and delusions associated with Parkinson’s disease psychosis. The generic manufacturers pursued their own versions, and Acadia accused them of infringing its formulation patent. The patent’s requirements include granules—powder particles made to stick together—inside the capsule. After trial, a Delaware judge rejected the invalidity challenge and found Aurobindo’s proposed product infringed. Now the generic manufacturers will challenge the patent’s validity, and Aurobindo will also contest the infringement finding. Acadia will defend both rulings. Listen for the distinction between challenging the patent itself and disputing whether a particular product meets its requirements. Acadia Pharmaceuticals Inc. v. Aurobindo Pharma Ltd. (No. 25-1875) — U.S. Court of Appeals for the Federal
The D.C. Circuit hears Andrea Conte’s challenge to the FBI’s response to a Freedom of Information Act request. Conte sought decades-old records about Warren Hart, whom he alleges worked as an FBI informant inside Baltimore’s Black Panther Party. The FBI released some records but withheld other material. It also refused to confirm or deny whether certain categories of records existed—a position known as a Glomar response. Conte says public testimony and historical documents have already revealed Hart’s alleged role. The district court ruled for the FBI and allowed it to submit a confidential declaration that Conte could not see. Conte will argue that existing disclosures defeat the refusal to acknowledge those files, and that more public explanation should have been required. The government will defend the confidentiality protections and argue that public allegations or another agency’s disclosures are not an official acknowledgment by the FBI. Listen for how a court can test a secrecy
The D.C. Circuit reviews the Drug Enforcement Administration’s decision to revoke Prescript Pharmaceuticals’ registration. Prescript buys finished medicines from other companies and repackages them for sale. It purchased controlled opioids without obtaining procurement quotas—annual authorizations limiting how much it could buy. Prescript says the quota rule then in force covered turning drug ingredients into medicines, not repackaging pills that already existed. The DEA disagreed: it suspended the registration in November 2023 and later ordered revocation after an administrative hearing. The agency cited repeated failures to follow its quota requirements and a lack of assurance that Prescript would comply in the future. Prescript will challenge both the rule’s interpretation and the sanction, arguing that maintaining its legal position should not count as refusing to comply. The government will defend the rule’s coverage and the agency’s assessment of whether the company could be trus
The Seventh Circuit hears an appeal by Evan and Michelle Beine after their lawsuit against a hospital and medical providers was dismissed as too late. In 2020, they brought their infant to the hospital with a broken leg. Staff reported suspected child abuse; Evan was arrested, and the parents’ contact with their child was restricted. The parents say later medical reviews showed a bone condition could explain findings that had been attributed to abuse. They sued in 2025, alleging that the medical assessments had wrongly led to family separation and other harm. The district court said a three-year filing period had already expired because they knew of their injury and its source by early 2021. The parents will argue that later discoveries matter and that dismissal was premature before the facts could be developed. The defendants will argue that the parents already knew enough to sue well before those later medical reviews. Listen for the difference between knowing that you have been harm
The Federal Circuit hears Hendricks versus the Department of Homeland Security, a challenge to the firing of a Border Patrol supervisor over Facebook posts. Thomas Hendricks posted to a group of current and former agents. The central post used a sexually explicit, altered image of President Trump and a congresswoman. Customs and Border Protection fired him for conduct unbecoming a supervisor. An administrative judge upheld the removal, and the Merit Systems Protection Board said that this one post alone justified the misconduct charge and the penalty. Hendricks will argue that his posts were protected speech and that the penalty was not properly justified. The government will defend the firing as a reasonable response to misconduct that harmed the agency. This is an employment-discipline case, not a criminal prosecution: listen for how that distinction affects the free-speech debate, and whether the board adequately justified firing him. Hendricks v. DHS (No. 25-1777) — U.S. Court of A
The Federal Circuit hears Gill versus Collins, a veterans-benefits dispute over whether an old letter counted as an appeal. VA had turned down Gill’s request for benefits for post-traumatic stress disorder, or PTSD, in 2008. In 2009, he wrote asking for benefits for depression, the condition identified at a VA examination. VA treated that letter as a new claim, rather than an appeal of the earlier decision. Under the older rules, an appeal began with a notice of disagreement—a written expression of disagreement and a request for review. The Veterans Court upheld the finding that the letter did not count, considering his earlier filings as evidence of what he intended. Gill will argue that this approach unfairly holds experienced veterans to a higher standard. The government will defend the use of context and say his challenge simply asks the court to reweigh evidence. Listen for the difference between interpreting a veteran’s letter and interpreting the rule that governs it, and why th
The D.C. Circuit hears an appeal by Prescript Pharmaceuticals over the dismissal of its lawsuit against the federal government. Prescript is a California company that buys finished drugs, repackages them, and resells them. The Drug Enforcement Administration says it ordered certain controlled drugs without the required purchasing quotas; Prescript disputes that those rules applied to its repackaging business. In November 2023, the agency immediately suspended Prescript’s registration, citing imminent danger to public health or safety, and agents seized drugs from the company. Prescript sued to challenge that emergency action and seek its property back. While that lawsuit was pending, the agency issued a final decision revoking the registration. The district court then dismissed the suit, reasoning that review now belonged exclusively in a federal appeals court. Prescript will argue that the emergency suspension and seized property still require their own court review; the government wi
The Federal Circuit hears a patent dispute between Guntert and Zimmerman and GOMACO over concrete paving machines. Guntert and Zimmerman sued GOMACO, alleging that its machines used the patented arrangement of support legs. Those legs connect the machine’s central frame to the tracks that carry it over the ground. The patent distinguishes a forward connection through a support called a bolster from a connection along the side. The patent holder says the same connection on GOMACO’s machine can satisfy both descriptions. The district court rejected that theory as inconsistent with the patent’s requirements, keeping the infringement claim from proceeding. Guntert and Zimmerman will challenge that reading and the decision to stop the case at the pleading stage; GOMACO will defend the dismissal. Listen for whether one connection can do two claimed jobs, and whether the court could resolve that dispute without further interpretation of the patent. Guntert & Zimmerman Const. Div., Inc. v. GOM
The Supreme Court considers whether a federal prisoner can sue a prison medical worker personally for money damages over allegedly denied medical care. After an assault at a federal detention center in Honolulu in 2021, Watanabe says he had severe back pain and that Nielsen refused his request to go to a hospital. His complaint describes repeated requests for more care and a broken-tailbone diagnosis months later. He sued under the Eighth Amendment, alleging deliberate indifference to his medical needs. His claim invokes Bivens, a court-recognized damages remedy against federal officials for certain constitutional violations, and Carlson versus Green, which applied it to prison medical care. The district court dismissed his claim, but the Ninth Circuit reinstated it. The question here is whether this kind of suit may proceed, not whether the medical worker has been proved liable. Nielsen will ask the Court to reject the suit and reconsider its damages precedents; Watanabe will contend
The Federal Circuit hears Blaze Mobile’s appeals over two patents for processing payments through a phone. The disputed claims divide the work among a phone app, a remote management server that authenticates the user, and a transaction server that processes the payment. After reexamining the patents, the Patent Office rejected their claims, and Blaze appealed. One distinction to keep in mind is checking a user’s identity versus approving a purchase: can the same PIN do both jobs under these claims? The argument also concerns which server must perform each function, and whether combining earlier technologies would supply the claimed arrangement. In Re Blaze Mobile, Inc. (No. 25-1485) — U.S. Court of Appeals for the Federal Circuit, argued November 9, 2026. Sources: Argument audio — official Federal Circuit recording for consolidated appeals 25-1484 and 25-1485; the 25-1485 recording reviewed here; complete argument with gentle volume balancing, no noise filtering or speech reconstructio
The Federal Circuit hears V L Collective’s appeal in a patent dispute with Netflix. The patent concerns keeping different media files, such as video and audio, synchronized. After the patent was asserted against Netflix, both Netflix and a separate organization called Unified Patents challenged it at the Patent Trial and Appeal Board. Unified’s case knocked out several patent claims, but two survived that challenge. In Netflix’s case, the Board later found all of the challenged claims unpatentable, including those two. V L Collective will contend that Netflix’s relationship with Unified should bind it to the earlier proceeding and bar Netflix’s challenge to claims already reviewed; Netflix will defend the Board’s decision to let its case proceed. The court will also examine whether the Board correctly matched the patent’s requirements to an older media-synchronization system. VL Collective IP, LLC v. Netflix, Inc. (No. 25-1525) — U.S. Court of Appeals for the Federal Circuit, argued No
The Federal Circuit hears Medytox's appeal in a dispute over the bacteria used to make botulinum toxin products. Medytox accused a rival manufacturer, Hugel, of wrongfully taking its bacterial culture and sought action against imported products at the United States International Trade Commission. An administrative law judge rejected the claim, and the Commission agreed that Medytox had not proved that its property had been converted. The earlier trade-secret allegations had already been removed from the investigation; the issue now is the alleged wrongful taking of property. Medytox will ask the court to overturn the Commission's finding, while the Commission will defend it. As you listen, keep the burden of proof in view: questioning a rival's story is not the same as proving that it took property that belonged to you. Medytox, Inc. v. ITC (No. 25-1262) — U.S. Court of Appeals for the Federal Circuit, argued November 9, 2026. Sources: Argument audio — official Federal Circuit recordin